Variation in the availability of cancer drug generics in the United States of America.

Variation in the availability of cancer drug generics in the United States of America.

While most of the attention and spending in the oncology community in the United States has been focused on the remarkable scientific inventions of the newer targeted drugs, the shortage of the older essential cancer drugs that are off patent, mostly generics and injectables, has a threatening impac...

書誌詳細
主要な著者:	Elzawawy, A, Kerr, D
フォーマット:	Journal article
言語:	English
出版事項:	2013

類似資料

Generic drugs: their role in better value cancer care.
著者:: Kerr, D
出版事項: (2013)

Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States
著者:: Chin-Fun Chu, 等
出版事項: (2012-01-01)

Paying physicians to prescribe generic drugs and follow-on biologics in the United States.
著者:: Ameet Sarpatwari, 等
出版事項: (2015-03-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
著者:: Varsha Bangalee, 等
出版事項: (2016-10-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
著者:: Varsha Bangalee, 等
出版事項: (2016-12-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
著者:: F. V. Gorkavenko, 等
出版事項: (2019-07-01)

The Quality of Generic Drugs Available in Hospital Drugs List: A Case Study of Songklanagarind Hospital
著者:: Dusit Supawatanawong
出版事項: (2014-06-01)

Targeted therapies: Manufacturer sponsorship bias in economic analyses matters.
著者:: Kerr, D, 等
出版事項: (2012)

Targeted therapies: Manufacturer sponsorship bias in economic analyses matters
著者:: Kerr, D, 等
出版事項: (2012)

Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
著者:: Reddy M Vivek, 等
出版事項: (2022-03-01)

Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016
著者:: William S. Pearson, 等
出版事項: (2019-11-01)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
著者:: Huiyao Huang, 等
出版事項: (2022-07-01)

Variation of Cost among Anti-cancer Drugs Available in Indian Market
著者:: Bhanu Prakash Kolasani, 等
出版事項: (2016-11-01)

United States of America
著者:: Bobbi A. Kerlin
出版事項: (2000-01-01)

Universal Healthcare in the United States of America: A Healthy Debate
著者:: Gabriel Zieff, 等
出版事項: (2020-10-01)

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.
著者:: Matthias Samwald, 等
出版事項: (2016-01-01)

The effect of generic market entry on antibiotic prescriptions in the United States
著者:: Cecilia Kållberg, 等
出版事項: (2021-05-01)

Variation in adverse drug events of opioids in the United States
著者:: Edward Y. Liu, 等
出版事項: (2023-03-01)

Mathematics test available in the United States/
著者:: 236909 Myers, Sheldon S., 等
出版事項: (1972)

Persistent geographic variations in availability and quality of nursing home care in the United States: 1996 to 2016
著者:: Yun Wang, 等
出版事項: (2019-04-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
著者:: Karan eThakkar, 等
出版事項: (2013-09-01)

Generic drugs for public health in India:………unbranded versus branded generics
著者:: M M Nagargoje, 等
出版事項: (2017-01-01)

Mapping COVID vulnerability in relation to drug and alcohol recovery residence availability across the United States
著者:: Amy A. Mericle, 等
出版事項: (2023-11-01)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
著者:: Muhammad M. Hammami, 等
出版事項: (2017-12-01)

Generic Substitutions for Antiepileptic Drugs
著者:: J Gordon Millichap
出版事項: (1990-11-01)

Generic Drugs or Branded Generics, Which One You Prefer to Prescribe?
著者:: Manjunath Premanath, 等
出版事項: (2024-03-01)

Widespread Availability of Artemisinin Monotherapy in the United States
著者:: Robert M. Rakita, 等
出版事項: (2011-05-01)

The availability of pharmacies in the United States: 2007-2015.
著者:: Dima Mazen Qato, 等
出版事項: (2017-01-01)

Generic drugs: benefit/risk ratio
著者:: E. A. Ushkalova, 等
出版事項: (2021-12-01)

The epidemiological trends of biliary tract cancers in the United States of America
著者:: Yong Jiang, 等
出版事項: (2022-12-01)

The "Win-Win" initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy
著者:: Elzawawy Ahmed
出版事項: (2009-05-01)

Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal income
著者:: Takaaki Suzuki, 等
出版事項: (2023-02-01)

Determinants of delayed detection of cancers in Texas Counties in the United States of America
著者:: Gong Gordon, 等
出版事項: (2012-05-01)

NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT
著者:: D. V. Goryachev, 等
出版事項: (2018-03-01)

The United States of America and scientific research.
著者:: Gregory J Hather, 等
出版事項: (2010-08-01)

More research is needed for generic drugs
著者:: Silvio Garattini
出版事項: (2012-10-01)

Generic drugs: myths, facts, and limitations
著者:: Antonio Marzo, 等
出版事項: (2012-10-01)

More vigilance on generic drugs are necessary
著者:: Mathew John
出版事項: (2020-01-01)

New prices for generic equivalent drugs
著者:: Ombretta Bandi
出版事項: (2011-11-01)

Determinants of generic drug substitution in Switzerland
著者:: Lufkin Thomas M, 等
出版事項: (2011-01-01)